• 1
    Harper P, Floderus Y, Holmstrom P, Eggertsen G, Gafvels M. Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda. J Inter Med 2004; 255: 6847.
  • 2
    Bulaj ZJ, Phillips JD, Aljoka RS et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 156571.
  • 3
    Trombini P, Mauri V, Salvioni A, Corengia C, Arosio C, Piperno A. S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload. Haemologica 2001; 86: 3167.
  • 4
    Enriquez de Salamanca R, Morales P, Castro MJ, Rojo R, Gonzalez M, Arraiz-Villena A. The most frequent HFE allele linked to porphyria cutanea tarda in Mediterranean is His63Asp. Hepatology 1999; 30: 81920.
  • 5
    Garcia Morillo JS, Carneado de la Fuente J, Stiefel P, Garcia-Donas MA, González Escribano MF, Nuñez Roldan A. Study of the gene of hemocromatosis in first degree relatives of patients with porphyria cutanea tarda. Med Clin (Barc) 1999; 112: 699701.
  • 6
    Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutaded in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399408.
  • 7
    Bygum A, Christiansen L, Petersen NE, Horder M, Thomsem K, Brandrup B. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol 2003; 83: 11520.